| scholarly article | Q13442814 |
| P50 | author | Chad Vezina | Q42876741 |
| Ling Hao | Q59698407 | ||
| Charles J Bieberich | Q84288073 | ||
| P2093 | author name string | Samuel Thomas | |
| Lingjun Li | |||
| William A Ricke | |||
| Yatao Shi | |||
| Arya Ashok | |||
| Sagar Bajpai | |||
| P2860 | cites work | Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 |
| MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis | Q24632755 | ||
| Urine metabolomics for kidney cancer detection and biomarker discovery | Q27013059 | ||
| Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection | Q27321863 | ||
| Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS) | Q28547212 | ||
| The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial | Q31137576 | ||
| Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet | Q33521220 | ||
| MBRole: enrichment analysis of metabolomic data | Q33786473 | ||
| Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer | Q33854379 | ||
| Qualitative metabolome analysis of human cerebrospinal fluid by 13C-/12C-isotope dansylation labeling combined with liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry | Q33864839 | ||
| A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate | Q34049857 | ||
| IL-1 induces IGF-dependent epithelial proliferation in prostate development and reactive hyperplasia | Q34171551 | ||
| American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited | Q34236446 | ||
| Genetically engineered mouse models: closing the gap between preclinical data and trial outcomes | Q34272078 | ||
| Urinary bladder contraction and relaxation: physiology and pathophysiology | Q34335220 | ||
| Genetically engineered models have advantages over xenografts for preclinical studies | Q34508688 | ||
| Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate | Q34514525 | ||
| EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction | Q34642314 | ||
| Prostatic fibrosis, lower urinary tract symptoms, and BPH | Q34822091 | ||
| Relative quantification of amine-containing metabolites using isobaric N,N-dimethyl leucine (DiLeu) reagents via LC-ESI-MS/MS and CE-ESI-MS/MS. | Q34859719 | ||
| Models of inflammation of the lower urinary tract | Q35041139 | ||
| Prostatic inflammation induces urinary frequency in adult mice | Q35043971 | ||
| The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease | Q35155012 | ||
| Experimental autoimmune cystitis: a potential murine model for ulcerative interstitial cystitis | Q35525960 | ||
| Investigation of signaling molecules and metabolites found in crustacean hemolymph via in vivo microdialysis using a multifaceted mass spectrometric platform. | Q35874615 | ||
| Molecular and cellular pathogenesis of benign prostatic hyperplasia | Q35947115 | ||
| Highly-accurate metabolomic detection of early-stage ovarian cancer. | Q36285567 | ||
| A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder | Q36418714 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| The detrusor muscle: an innocent victim of bladder outlet obstruction. | Q36595583 | ||
| Nicotine and serotonin in immune regulation and inflammatory processes: a perspective | Q36654672 | ||
| Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? | Q36689428 | ||
| Biomarker discovery in mass spectrometry-based urinary proteomics | Q36956324 | ||
| In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms. | Q37159996 | ||
| Mass Defect-Based N,N-Dimethyl Leucine Labels for Quantitative Proteomics and Amine Metabolomics of Pancreatic Cancer Cells. | Q37682589 | ||
| CE-MS for metabolomics: developments and applications in the period 2010-2012. | Q38060598 | ||
| Sample normalization methods in quantitative metabolomics | Q38695537 | ||
| Quantitative analysis of serotonin secreted by human embryonic stem cells-derived serotonergic neurons via pH-mediated online stacking-CE-ESI-MRM. | Q38801279 | ||
| Chronic Prostate Inflammation Predicts Symptom Progression in Patients with Chronic Prostatitis/Chronic Pelvic Pain | Q39019521 | ||
| Normalization to specific gravity prior to analysis improves information recovery from high resolution mass spectrometry metabolomic profiles of human urine | Q39118178 | ||
| Combination of injection volume calibration by creatinine and MS signals' normalization to overcome urine variability in LC-MS-based metabolomics studies. | Q39125770 | ||
| Altered polyamine profiles in prostatic hyperplasia and in kidney tumors | Q39496435 | ||
| Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study | Q41131628 | ||
| Prostatic fibrosis is associated with lower urinary tract symptoms | Q41595234 | ||
| Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer. | Q42140458 | ||
| Hoxb13 regulatory elements mediate transgene expression during prostate organogenesis and carcinogenesis | Q42220559 | ||
| Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery. | Q45901663 | ||
| Economic costs of benign prostatic hyperplasia in the private sector. | Q45993292 | ||
| Normalization strategies for metabonomic analysis of urine samples. | Q46137413 | ||
| Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-deficient mice | Q46536231 | ||
| Increased arginase activity in cystic fibrosis airways | Q46706389 | ||
| Fractional factorial design based microwave-assisted extraction for the determination of organophosphorus and organochlorine residues in tobacco by using gas chromatography-mass spectrometry. | Q51059850 | ||
| Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. | Q53590617 | ||
| Optimized Preprocessing of Ultra-Performance Liquid Chromatography/Mass Spectrometry Urinary Metabolic Profiles for Improved Information Recovery | Q58045605 | ||
| Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease | Q59880162 | ||
| Effect of inflammatory and noninflammatory stress on ketone bodies and free fatty acids in rats | Q67647392 | ||
| Processing of precursor interleukin 1 beta and inflammatory disease | Q68453302 | ||
| ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder | Q70728936 | ||
| An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy | Q80791706 | ||
| Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality | Q81426580 | ||
| P304 | page(s) | 185-192 | |
| P577 | publication date | 2018-09-22 | |
| P1433 | published in | International Journal of Mass Spectrometry | Q534231 |
| P1476 | title | Comprehensive urinary metabolomic characterization of a genetically induced mouse model of prostatic inflammation | |
| P478 | volume | 434 |
Search more.